CSPC Pharmaceutical Group Limited (CHJTF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CSPC Pharmaceutical Group...

    OTC: CHJTF · Real-Time Price · USD
    1.27
    0.00 (0.00%)
    At close: Aug 05, 2025, 12:35 PM
    1.27
    0.00%
    After-hours: Aug 27, 2025, 08:00 PM EDT

    CSPC Pharmaceutical Income Statement

    Financials in HKD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 38.84B 41.05B 42.67B 43.93B 34.46B 32.77B 41.63B 52.13B 61.1B 53.05B 52.43B 47.72B 44.61B
    Cost of Revenue
    		 11.88B 12.1B 14.75B 14.69B 12.02B 11.86B 12.02B 14.95B 16.8B 14.26B 13.27B 11.67B 10.99B
    Gross Profit
    		 26.95B 28.95B 36.18B 36.94B 30.13B 28.61B 29.04B 37.18B 44.3B 38.78B 39.16B 36.05B 33.62B
    Operating Income
    		 7.31B 7.9B 9.11B 9.97B 7.9B 7.44B 9.24B 11.56B 13.45B 11.7B 11.71B 10.86B 9.85B
    Interest Income
    		 n/a n/a n/a n/a 141.15M 141.15M 302.79M 421.7M 411.55M 411.55M 339.91M 308.39M 206.58M
    Pretax Income
    		 7.94B 8.25B 9.32B 10.34B 8.16B 7.71B 10.1B 12.52B 14.45B 12.67B 12.71B 12.19B 11.57B
    Net Income
    		 6.25B 6.42B 7.21B 8.01B 6.3B 5.98B 8.11B 10.06B 11.59B 10.17B 10.33B 10.01B 9.48B
    Selling & General & Admin
    		 12.54B 14.08B 14.14B 14.27B 11.15B 10.33B 10.41B 15.19B 19.35B 16.6B 21.04B 19.41B 18.59B
    Research & Development
    		 7.1B 6.97B 6.79B 6.78B 5.34B 5.08B 6.14B 6.94B 7.84B 6.84B 6.41B 5.78B 5.18B
    Other Expenses
    		 n/a n/a 244.58M 422.33M 422.33M 438.97M 566.33M 388.58M 388.58M 371.94M n/a n/a n/a
    Operating Expenses
    		 19.64B 21.05B 21.18B 21.48B 16.95B 15.89B 20.42B 25.83B 30.85B 27.08B 27.45B 25.19B 23.78B
    Interest Expense
    		 n/a n/a 9.02M 15.17M 21.47M 25.9M 33.9M 39.48M 36.68M 32.25M 20.97M 16.87M 19.51M
    Selling & Marketing Expenses
    		 11.13B 12.56B 12.5B 12.58B 9.86B 9.14B 9.26B 7.13B 4.71B 2.22B n/a n/a n/a
    Cost & Expenses
    		 31.52B 33.16B 33.56B 33.96B 26.77B 25.55B 32.6B 40.77B 47.65B 41.34B 40.72B 36.86B 34.76B
    Income Tax Expense
    		 1.66B 1.8B 1.84B 1.99B 1.49B 1.34B 1.73B 2.2B 2.62B 2.31B 2.23B 2.08B 1.97B
    Shares Outstanding (Basic)
    		 11.45B 11.57B 11.71B 11.84B 11.85B 11.85B 11.88B 11.89B 11.92B 11.93B 11.92B 11.95B 11.95B
    Shares Outstanding (Diluted)
    		 11.45B 11.57B 11.71B 11.84B 11.85B 11.85B 11.88B 11.89B 11.92B 11.93B 11.92B 11.95B 11.96B
    EPS (Basic)
    		 0.53 0.54 0.62 0.68 0.69 0.66 0.82 0.99 0.97 0.85 0.87 0.84 0.79
    EPS (Diluted)
    		 0.53 0.54 0.62 0.68 0.69 0.66 0.82 0.99 0.97 0.85 0.87 0.84 0.79
    EBITDA
    		 8.84B 9.37B 10.49B 11.18B 8.52B 7.85B 9.99B 12.82B 15.23B 13.44B 13.33B 12.45B 11.34B
    EBIT
    		 7.41B 7.99B 9.15B 10.09B 8.01B 7.56B 7.58B 7.61B 9.57B 7.83B 9.55B 11.06B 9.99B
    Depreciation & Amortization
    		 1.42B 1.38B 1.35B 1.09B 1.1B 892.51M 1.27B 1.85B 1.78B 1.74B 1.62B 1.52B 1.42B

    Add to Watchlist